2025 annual financial data
Intensity Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -11,972,000 USD and net income was -11,606,000 USD.
Operating cash flow was -9,233,000 USD.
Get free Intensity Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,972,000 USD
- Net income
- -11,606,000 USD
- Operating cash flow
- -9,233,000 USD